OVERVIEW
At RevivalizeMD,
weight management is medicine,
not a fad diet.
Our physician-supervised programs combine FDA-approved pharmacotherapy with personalized lifestyle modification to help you achieve sustainable, medically significant weight loss. Every plan is built around your biology, your health history, and your goals.
We go beyond the scale. Our approach addresses the hormonal, metabolic, and behavioral factors that make weight loss difficult and weight maintenance even harder. With regular physician oversight, body composition monitoring, and ongoing coaching, you're never doing this alone.
Treatment
OPTIONS
GLP-1 Receptor Agonists
-
Semaglutide: Weekly injectable that reduces appetite and slows gastric emptying. Clinically demonstrated to support significant weight reduction when combined with lifestyle changes.
-
Tirzepatide: Dual GIP/GLP-1 receptor agonist offering enhanced metabolic effects. Emerging as a leading option for patients seeking comprehensive metabolic support.
Cagrilintide Companion Therapy
For patients on GLP-1 therapy, cagrilintide can be added as a companion treatment to enhance results. This amylin analog works synergistically with GLP-1s to further reduce appetite and improve metabolic outcomes.
Nutritional Counseling & Lifestyle Coaching
Every program includes personalized nutritional guidance and behavioral coaching. We help you build sustainable habits around meal planning, movement, sleep, and stress management because medication alone is only part of the equation.
Body Composition Monitoring
Track your progress beyond the scale with regular body composition analysis, including lean mass, fat mass, visceral fat, and metabolic rate measurements.
Candidacy Criteria
Criterion
Details
BMI Thresholds
BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, sleep apnea).
Health Screening
Comprehensive metabolic panel, thyroid function, A1C, lipid panel. Additional labs as indicated by medical history.
Contraindications
Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, active pancreatitis, pregnancy or planned pregnancy, severe gastroparesis.
Expected Results Timeline
Timeframe
What to Expect
Weeks 1–4
Dose titration phase. Appetite suppression begins. Mild GI adjustment is common. Weight loss of 2–5 lbs typical.
Months 2–3
Therapeutic dose achieved. Significant appetite reduction. Most patients see 5–10% body weight reduction.
Months 4–6
Continued steady weight loss. Body composition shifts become visible. Energy and metabolic markers improve.
Months 6–12
Approaching peak results. 15–20%+ body weight reduction in many patients. Transition to maintenance phase planning begins.
Pricing Tiers
Starter
3 months
Physician consultation, lab panel, medication, 3 follow-up visits, body composition baseline.
Comprehensive
6 months
Everything in Starter + nutritional coaching, monthly body composition tracking, medication adjustments, 6 follow-ups.
Transformation
12 months
Full program with extended support, quarterly lab panels, unlimited coaching sessions, maintenance phase transition plan.
FAQ
GLP-1 receptor agonists have been extensively studied and are FDA-approved for weight management. As with any medication, there are potential side effects most commonly mild nausea during the titration phase. Our physician monitors you closely throughout your program.
Coverage varies by plan. Some insurers cover GLP-1 medications for patients with qualifying diagnoses. Our team can help verify your benefits. Self-pay options and payment plans are also available.
Our program is designed to build sustainable habits alongside pharmacotherapy. The lifestyle coaching and behavioral modifications you develop during your program are tools for long-term maintenance. We create a personalized step-down and maintenance plan.
Yes. Our weight loss programs are fully available via telehealth for qualifying patients. Virtual consultations, medication management, and coaching can all be done remotely.